78 related articles for article (PubMed ID: 26822263)
21. The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.
Venant H; Rahmaniyan M; Jones EE; Lu P; Lilly MB; Garrett-Mayer E; Drake RR; Kraveka JM; Smith CD; Voelkel-Johnson C
Mol Cancer Ther; 2015 Dec; 14(12):2744-52. PubMed ID: 26494858
[TBL] [Abstract][Full Text] [Related]
22. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine Kinase 1 Plays an Important Role in Atorvastatin-Mediated Anti-Inflammatory Effect against Acute Lung Injury.
Wu L; Cheng Y; Peng S; Zhang W; Zhang C
Mediators Inflamm; 2021; 2021():9247285. PubMed ID: 34970075
[TBL] [Abstract][Full Text] [Related]
25. Renal Mesangial Cells Isolated from Sphingosine Kinase 2 Transgenic Mice Show Reduced Proliferation and are More Sensitive to Stress-Induced Apoptosis.
Beyer S; Schwalm S; Pfeilschifter J; Huwiler A
Cell Physiol Biochem; 2018; 47(6):2522-2533. PubMed ID: 29991026
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity.
Poitevin S; Cussac D; Leroyer AS; Albinet V; Sarlon-Bartoli G; Guillet B; Hubert L; Andrieu-Abadie N; Couderc B; Parini A; Dignat-George F; Sabatier F
Cardiovasc Res; 2014 Jul; 103(1):121-30. PubMed ID: 24743591
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
28. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640.
White MD; Chan L; Antoon JW; Beckman BS
Anticancer Res; 2013 Sep; 33(9):3573-9. PubMed ID: 24023282
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine kinase 2 inhibitor ABC294640 suppresses neuronal excitability and inhibits multiple endogenously and exogenously expressed voltage-gated ion channels in cultured cells.
Zhang F; Hu W; Qu L; Cang C
Channels (Austin); 2020 Dec; 14(1):216-230. PubMed ID: 32615066
[TBL] [Abstract][Full Text] [Related]
30. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.
Kim M; Kim M; Kim N; D'Agati VD; Emala CW; Lee HT
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1827-35. PubMed ID: 17898040
[TBL] [Abstract][Full Text] [Related]
31. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice.
Oyama O; Sugimoto N; Qi X; Takuwa N; Mizugishi K; Koizumi J; Takuwa Y
Cardiovasc Res; 2008 May; 78(2):301-7. PubMed ID: 18187460
[TBL] [Abstract][Full Text] [Related]
32. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
[TBL] [Abstract][Full Text] [Related]
33. Role for sphingosine kinase 1 in colon carcinogenesis.
Kawamori T; Kaneshiro T; Okumura M; Maalouf S; Uflacker A; Bielawski J; Hannun YA; Obeid LM
FASEB J; 2009 Feb; 23(2):405-14. PubMed ID: 18824518
[TBL] [Abstract][Full Text] [Related]
34. Discovery and evaluation of inhibitors of human sphingosine kinase.
French KJ; Schrecengost RS; Lee BD; Zhuang Y; Smith SN; Eberly JL; Yun JK; Smith CD
Cancer Res; 2003 Sep; 63(18):5962-9. PubMed ID: 14522923
[TBL] [Abstract][Full Text] [Related]
35. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells.
Böhm A; Flößer A; Ermler S; Fender AC; Lüth A; Kleuser B; Schrör K; Rauch BH
Cardiovasc Res; 2013 Aug; 99(3):505-13. PubMed ID: 23658376
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Maines LW; Fitzpatrick LR; Green CL; Zhuang Y; Smith CD
Inflammopharmacology; 2010 Apr; 18(2):73-85. PubMed ID: 20151210
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine kinase regulates the rate of endothelial progenitor cell differentiation.
Bonder CS; Sun WY; Matthews T; Cassano C; Li X; Ramshaw HS; Pitson SM; Lopez AF; Coates PT; Proia RL; Vadas MA; Gamble JR
Blood; 2009 Feb; 113(9):2108-17. PubMed ID: 19109558
[TBL] [Abstract][Full Text] [Related]
38. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.
Bergelin N; Blom T; Heikkilä J; Löf C; Alam C; Balthasar S; Slotte JP; Hinkkanen A; Törnquist K
Endocrinology; 2009 May; 150(5):2055-63. PubMed ID: 19116345
[TBL] [Abstract][Full Text] [Related]
39. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling.
Youm JK; Jo H; Hong JH; Shin DM; Kwon MJ; Jeong SK; Park BD; Choi EH; Lee SH
J Dermatol Sci; 2008 Aug; 51(2):89-102. PubMed ID: 18420384
[TBL] [Abstract][Full Text] [Related]
40. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
